SeaStar Medical Holding Corp (ICUCW) stock
ICUCWNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31Also trades as ICU
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 12, 2026Score 3/309% above fair value
$0.01−0.01 (-34.73%)
Close on Oct 30, 2026Market cap $9.87MP/E –Yield –
SeaStar Medical operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
SeaStar Medical's operating cash flow for the twelve months ending Jun 30, 2026 was -$13.69M. For fiscal 2025 it was -$13.60M. The highest annual figure on record is -$5.11M in fiscal 2021.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$13.60M | – |
| FY2024 | Dec 31, 2024 | -$16.01M | – |
| FY2023 | Dec 31, 2023 | -$10.29M | – |
| FY2022 | Dec 31, 2022 | -$7.79M | – |
| FY2021 | Dec 31, 2021 | -$5.11M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$2.99M | – |
| Q1 FY2026 | Mar 31, 2026 | -$2.76M | – |
| Q4 FY2025 | Dec 31, 2025 | -$4.09M | – |
| Q3 FY2025 | Sep 30, 2025 | -$3.84M | – |
| Q2 FY2025 | Jun 30, 2025 | -$3.01M | – |
| Q1 FY2025 | Mar 31, 2025 | -$2.65M | – |
| Q4 FY2024 | Dec 31, 2024 | -$4.69M | – |
| Q3 FY2024 | Sep 30, 2024 | -$5.00M | – |
| Q2 FY2024 | Jun 30, 2024 | -$2.82M | – |
| Q1 FY2024 | Mar 31, 2024 | -$3.49M | – |
| Q4 FY2023 | Dec 31, 2023 | -$4.49M | – |
| Q3 FY2023 | Sep 30, 2023 | -$1.34M | – |
| Q2 FY2023 | Jun 30, 2023 | -$2.17M | – |
| Q1 FY2023 | Mar 31, 2023 | -$2.29M | – |
| Q4 FY2022 | Dec 31, 2022 | -$5.30M | – |
| Q3 FY2022 | Sep 30, 2022 | -$914.00K | – |
| Q2 FY2022 | Jun 30, 2022 | -$991.00K | – |
| Q1 FY2022 | Mar 31, 2022 | -$587.00K | – |
| Q4 FY2021 | Dec 31, 2021 | -$4.74M | – |
| Q3 FY2021 | Sep 30, 2021 | -$53.33K | – |
| Q2 FY2021 | Jun 30, 2021 | -$39.05K | – |
| Q1 FY2021 | Mar 31, 2021 | -$280.32K | – |